DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Quest Laboratories Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·10 Oct 2026, 10:32 am

Quest Laboratories

Quest Laboratories Limited has informed stock exchanges that it has obtained a certificate under SEBI's Depositories and Participants Regulations, 2018. This regulatory compliance is a standard requirement for entities that act as Depository Participants, a role involving the holding and servicing of securities in electronic form.

For investors, this development is a procedural update rather than a financial event. It confirms the company's adherence to the regulatory framework governing securities transactions. While it does not directly impact the company's business operations or financial performance, it ensures the company remains fully compliant with market regulations.

Investors should monitor this stock for any subsequent announcements regarding the specific scope of the certificate or other regulatory filings. As of now, the news does not signal any immediate changes to the company's operational outlook.